Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024
NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the […]
CapStar Financial Holdings, Inc. Announces Quarterly Dividend of $0.11 per Share
NASHVILLE, Tenn., Jan. 29, 2024 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ: CSTR) announced that on January 26, […]
USCB Financial Holdings, Inc. Initiates Quarterly Cash Dividend Program and Announces Declaration of First Cash Dividend
MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) — USCB Financial Holdings, Inc. (the “Company”) (NASDAQ: USCB), the holding company for U.S. […]
Auburn National Bancorporation, Inc. Reports Fourth Quarter and Full Year Results
AUBURN, Ala., Jan. 29, 2024 (GLOBE NEWSWIRE) — Auburn National Bancorporation (Nasdaq: AUBN) reported a net loss of $4.0 million, […]
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
The UK MHRA approval follows approvals by the U.S. FDA and the European Commission Cidara is entitled to receive a […]
German American Bancorp, Inc. (GABC) Posts Solid 4th Quarter and Annual 2023 Earnings; Declares 8% Cash Dividend Increase
JASPER, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (Nasdaq: GABC) reported solid annual earnings of $85.9 […]
Laureate Education Announces Date of Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) — Laureate Education, Inc. (NASDAQ: LAUR) plans to release results for the quarter and […]
Regency Centers Ranks 6th on America’s Most Responsible Companies List by Newsweek
JACKSONVILLE, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) — For the fifth consecutive year, Regency Centers Corporation (“Regency Centers” or the […]
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
Charlotte, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) […]
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), […]
